SEC Form 13F-HR · institutional holdings · free

Farallon Capital Management 13F holdings

The latest 13F-HR filed by Farallon Capital Management covers the period ending 2026-06-30, with 89 reported positions. The largest positions by reported value are below, as filed.

CIK 0000909661 · accession 0000908834-26-000432 · view the filings on SEC EDGAR · source: SEC EDGAR, Form 13F-HR information table
Period
2026-06-30
Filed
2026-08-14
Positions
89
Reported value
$21,675,731,270
#IssuerClassCUSIPValueSharesWeight
1STATE STR SPDR S&P 500 ETF TTR UNIT78462F103$4,480,620,0006,000,00020.7%
2REVOLUTION MEDICINES INCCOM76155X100$2,537,793,07513,550,79611.7%
3ELECTRONIC ARTS INCCOM285512109$1,623,814,2807,919,5007.5%
4BRIDGEBIO PHARMA INCCOM10806X102$800,143,33210,743,0633.7%
5PROTAGONIST THERAPEUTICS INCCOM74366E102$778,248,8976,348,9063.6%
Positions are folded by CUSIP: this filing lists 89 line items across 89 securities. A 13F reports long US-listed equity positions held at the period end, filed up to 45 days later. It is a snapshot, not a live portfolio, and it excludes shorts, cash and most non-US holdings.

What Farallon Capital Management bought, added, trimmed and exited

The free view above is the top of one quarter's filing. The paid report diffs the two most recent 13F filings, so you see new positions, adds, trims and exits with the size of each move, a cited write-up, and the full holdings plus changes table to download.

agents: POST /v1/fund with {"manager":"Farallon Capital Management"} over x402 or MPP, $4

Sample output and API docs · all reports

All 13F fund pagesInsider filings by tickerAll reportsWatch Farallon Capital Management for new 13F filings

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.